Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Neuroscience Unit, Kenya Medical Research Institute-Wellcome Trust Research Program, Kilifi, Kenya.
Compr Psychiatry. 2023 May;123:152382. doi: 10.1016/j.comppsych.2023.152382. Epub 2023 Mar 3.
Both fatal and nonfatal suicidal behaviours are important complications of mental, neurological, and substance use disorders (MNSDs) worldwide. We aimed at quantifying the association of suicidal behaviour with MNSDs in Low and Middle Income Countries (LMICs) where varying environmental and socio-cultural factors may impact outcome.
We conducted a systematic review and meta-analysis to report the associations between MNSDs and suicidality in LMICs and the study-level factors of these associations. We searched the following electronic databases: PUBMED, PsycINFO, MEDLINE, CINAHL, World Cat, and Cochrane library for studies on suicide risk in MNSDs, with a comparison/control group of persons without MNSDs, published from January 1, 1995 to September 3, 2020. Median estimates were calculated for relative risks for suicide behaviour and MNSDs, and when appropriate, these were pooled using random effects metanalytic model. This study was registered with PROSPERO, CRD42020178772.
The search identified 73 eligible studies: 28 were used for quantitative synthesis of estimates and 45 for description of risk factors. Studies included came from low and upper middle-income countries with a majority of these from Asia and South America and none from a low-income country. The sample size was 13,759 for MNSD cases and 11,792 hospital or community controls without MNSD. The most common MNSD exposure for suicidal behaviour was depressive disorders (47 studies (64%)), followed by schizophrenia spectrum, and other psychotic disorders (28 studies (38%)). Pooled estimates from the meta-analysis were statistically significant for suicidal behaviour with any MNSDs (odds ratios (OR) = 1∙98 (95%CI = 1∙80-2∙16))) and depressive disorder (OR = 3∙26 (95%CI = 2∙88-3∙63))), with both remaining significant after inclusion of high-quality studies only. Meta-regression identified only hospital-based studies (ratio of OR = 2∙85, CI:1∙24-6∙55) and sample size (OR = 1∙00, CI:0∙99-1∙00) as possible sources of variability in estimates. Risk for suicidal behaviour in MNSDs was increased by demographic factors (e.g., male sex, and unemployment), family history, psychosocial context and physical illness.
There is an association between suicidal behaviour and MNSDs in LMICs, the association is greater for depressive disorder in LMICs than what has been reported in High Income Countries (HICs). There is urgent need to improve access for MNSDs care in LMICs.
None.
在全球范围内,精神、神经和物质使用障碍(MNSD)会导致致命和非致命的自杀行为等严重并发症。我们旨在量化自杀行为与中低收入国家(LMIC)中 MNSD 之间的关联,因为环境和社会文化因素的差异可能会影响结果。
我们进行了系统评价和荟萃分析,以报告 MNSD 与 LMIC 中自杀行为之间的关联,以及这些关联的研究水平因素。我们检索了以下电子数据库:PubMed、PsycINFO、MEDLINE、CINAHL、WorldCat 和 Cochrane 图书馆,检索了 1995 年 1 月 1 日至 2020 年 9 月 3 日期间发表的 MNSD 自杀风险的比较/对照组研究。对于自杀行为和 MNSD 的相对风险,计算了中位数估计值,并且在适当的情况下,使用随机效应荟萃分析模型对这些估计值进行了汇总。本研究已在 PROSPERO 注册,CRD42020178772。
搜索共确定了 73 项符合条件的研究:其中 28 项用于定量综合评估,45 项用于描述危险因素。这些研究来自中低收入国家,其中大多数来自亚洲和南美洲,没有来自低收入国家的研究。MNSD 病例的样本量为 13759 例,无 MNSD 的医院或社区对照为 11792 例。自杀行为最常见的 MNSD 暴露是抑郁障碍(47 项研究(64%)),其次是精神分裂症谱系和其他精神病性障碍(28 项研究(38%))。荟萃分析的合并估计值在统计学上具有显著性,表明自杀行为与任何 MNSD(比值比(OR)=1.98(95%CI 1.80-2.16))和抑郁障碍(OR=3.26(95%CI 2.88-3.63)))相关,并且在仅包括高质量研究后仍然具有统计学意义。元回归仅确定了医院为基础的研究(比值比(OR)=2.85,CI:1.24-6.55)和样本量(OR=1.00,CI:0.99-1.00)是估计值变异性的可能来源。MNSD 中自杀行为的风险增加与人口统计学因素(例如,男性、失业)、家族史、心理社会背景和身体疾病有关。
在中低收入国家(LMIC)中,自杀行为与 MNSD 之间存在关联,这种关联在中低收入国家(LMIC)中抑郁障碍的关联比高收入国家(HIC)中报告的关联更为显著。迫切需要改善中低收入国家 MNSD 护理的获取。
无。